John Quiring

John is principally a scientist and has applied his statistical education interactively with clients/sponsors, regulatory officials, and co-workers with the goal of advancing the availability of medical products for over 40 years. As founder of QST, the predecessor name of Abond CRO Inc., he spearheaded the approval of over 90 regulatory submissions participating in strategic FDA / sponsor meetings, performing statistical analyses as well as directing the company’s work efforts. He has served as CEO and is now the Chief Scientific Officer and a member of the Board of Directors.